Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists.
about
The involvement of TRPV1 in emesis and anti-emesisSynthetic and natural antioxidants attenuate cisplatin-induced vomitingPranlukast prevents cysteinyl leukotriene-induced emesis in the least shrew (Cryptotis parva).Exercise-induced nausea and vomiting: another sign and symptom of pheochromocytoma and paragangliomaSubstance p regulates puberty onset and fertility in the female mouse.Delta 9-tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew.The antiemetic interaction of Delta9-tetrahydrocannabinol when combined with tropisetron or dexamethasone in the least shrewAblation of least shrew central neurokinin NK1 receptors reduces GR73632-induced vomiting.Receptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew (Cryptotis parva).Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the art.Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting.Profile of Antiemetic Activity of Netupitant Alone or in Combination with Palonosetron and Dexamethasone in Ferrets and Suncus murinus (House Musk Shrew).Neurokinin-1 receptor blocker CP-99 994 improved emesis induced by cisplatin via regulating the activity of gastric distention responsive neurons in the dorsal motor nucleus of vagus and enhancing gastric motility in rats.NK2 and NK1 receptor-mediated effects of NKA and analogs on colon, bladder, and arterial pressure in anesthetized dogs.
P2860
Q26745801-9BFCEA2A-D68A-427E-90C1-78A39424B951Q30834914-4FAD10A2-6061-412E-9807-47C0433D3782Q33638271-EF8BA6B5-0581-46A4-B0ED-A6101E79D0A7Q34034282-069395B8-ACAA-4BAE-BDD8-AA6C35A6BEC8Q35603388-237EE86A-00F4-4991-86B5-7C57118F2EF8Q37036977-E2EEC8FF-754F-4A9F-A4AF-17CFD99A6F21Q37101114-5BC84624-BA03-4DBA-9CFC-B039542B6EBEQ37271198-F9856768-7676-4B72-930E-AD3B8E4FDA24Q37407809-F39193C9-1880-4F8D-9E5F-E7547009C825Q37802795-8A975A2D-D282-4B15-B2A0-4B5C3EBF4E0DQ38974456-0366C49F-59D7-43E1-85F2-A4CACF4F40CAQ40978787-070EB718-8B04-4A69-9D07-2E3C9B9DAA54Q48062468-B9974EC8-7913-4A75-8111-F20E8EA51E86Q49564916-FEDD7033-A79A-484F-976E-01A3A325A7F9
P2860
Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Utilization of the least shrew ...... and NK1 receptor antagonists.
@ast
Utilization of the least shrew ...... and NK1 receptor antagonists.
@en
type
label
Utilization of the least shrew ...... and NK1 receptor antagonists.
@ast
Utilization of the least shrew ...... and NK1 receptor antagonists.
@en
prefLabel
Utilization of the least shrew ...... and NK1 receptor antagonists.
@ast
Utilization of the least shrew ...... and NK1 receptor antagonists.
@en
P2093
P2860
P1433
P1476
Utilization of the least shrew ...... and NK1 receptor antagonists.
@en
P2093
Andrew P Ray
Gerald R Thrush
Joseph Abad
Juan Ramirez
Nissar A Darmani
Yaozhi Wang
P2860
P356
10.1016/J.BRAINRES.2008.03.077
P407
P577
2008-04-09T00:00:00Z